ELI LILLY & Co (LLY) stock
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3026% above fair value
$1431.67−11.83 (-0.82%)
Close on Nov 16, 2026Market cap $1.35TP/E 46.5Yield 0.44%
Eli Lilly EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Eli Lilly's EV/EBITDA was 37.4× on Nov 11, 2026, against 39.6× a year earlier. Over the last 5 years it ranged from 27.6× to 86.8×, with a median of 41.4×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 37.4× | −2.2 |
| 2025 | Dec 31, 2025 | 39.5× | −18.4 |
| 2024 | Dec 31, 2024 | 58.0× | −9.3 |
| 2023 | Dec 29, 2023 | 67.3× | +26.6 |
| 2022 | Dec 30, 2022 | 40.7× | +9.8 |
| 2021 | Dec 31, 2021 | 30.9× | +10.1 |
| 2020 | Dec 31, 2020 | 20.7× | −2.4 |
| 2019 | Dec 31, 2019 | 23.1× | −2.0 |
| 2018 | Dec 31, 2018 | 25.1× | +3.9 |
| 2017 | Dec 29, 2017 | 21.2× | +3.1 |
| 2016 | Dec 30, 2016 | 18.1× | −3.0 |
| 2015 | Dec 31, 2015 | 21.1× | +11.0 |
| 2014 | Dec 31, 2014 | 10.1× | +1.6 |
| 2013 | Jan 31, 2013 | 8.5× | +0.7 |
| 2012 | Dec 31, 2012 | 7.8× | – |
See a number that looks wrong?